Stephanie Tcherny
Global Head of Benefit-Risk Evaluation - Sanofi
Stephanie, public health physician, has over 17 years of experience working in pharma companies on Pharmacoepidemiology and BR evaluation to support market access, pricing and risk management plans. After her appointments at Eli Lilly, she joined Global Pharmacovigilance & Epidemiology department at Sanofi in 2010 as a Global Pharmacoepidemiologist, as a Pharmacoepidemiology Lead in 2016 and Head of Benefit-Risk evaluation in 2017. Stephanie is one of the leading experts in the qualitative and quantitative BR field and has conducted several benefit-risk analyses for development and marketed drugs for over 10 years.
Sessions
-
Tuesday - November 23, 2021 - 10:30
Applying a structured approach to benefit-risk assessment and illustrating how it can make a difference in decision making purposes and regulatory approvals of medicinal products
Stay Informed
Subscribe today to receive news on latest updates,
offers and upcoming conferences via email
follow us
Follow us online to stay up to date about our conferences
For general conference and registration enquires please contact the below email id or fill out the form
info@corvusglobalevents.com
+44 (0) 207 096
0786
Experience the power of community building
Comprehensive Event Listings
Swift Event Registration
Enhanced Networking Opportunities
In-App Chat Feature
Schedule Meetings
Interactive session participation
Real-time event updates and notifications
Feedback and survey tools
Badge Scanning
Robust security and data protection
Continuous Connectivity for long-term professional relationships
